Page last updated: 2024-08-24

atorvastatin and Aging

atorvastatin has been researched along with Aging in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (23.33)29.6817
2010's19 (63.33)24.3611
2020's4 (13.33)2.80

Authors

AuthorsStudies
Battegay, M; Cavassini, M; Courlet, P; Decosterd, L; Marzolini, C; Saldanha, SA; Stader, F; Stoeckle, M1
Alves Saldanha, S; Buclin, T; Cavassini, M; Courlet, P; Csajka, C; Decosterd, LA; Guidi, M; Marzolini, C; Stader, F; Stoeckle, M1
Gao, Q; Gao, T; Guan, L; Hu, Y; Jiang, J; Li, T; Liu, P; Qiao, H; Sheng, W; Xue, X1
Hoffmann, TJ; Iribarren, C; Krauss, RM; Lu, B; Medina, MW; Oni-Orisan, A; Risch, N; Seraydarian, M; Sun, L1
Allahtavakoli, M; Fatemi, I; Kaeidi, A; Kaviani, E; Mozafari, N; Rahmani, M; Shamsizadeh, A1
Koca, RÖ; Kutlu, S; Nurullahoğlu-Atalık, KE; Solak, H1
Becker, ML; de Keyser, CE; Hofman, A; Klungel, OH; Maitland-van der Zee, AH; Peters, BJ; Stricker, BH; Uitterlinden, AG; Verstuyft, C; Visser, LE1
Han, L; Li, MG; Ye, P1
Fu, G; Gong, X; Ma, Y; Ruan, Y; Wu, S1
de Ceuninck, M; Trenson, S1
de Oliveira, RM; Ferreira, ED; Godinho, J; Milani, H; Previdelli, IS; Ribeiro, MH; Zaghi, GG1
Aubry, T; Bourgeois, N; Desfontis, JC; Didier, R; Dubreuil, M; Gilard, M; Goanvec, C; Le Grand, Y; Mallem, Y; Mansourati, J; Pichavant-Rafini, K; Plee-Gautier, E; Roquefort, P; Theron, M; Tissier, F1
Camerino, C; Camerino, GM; Cannone, M; Conte Camerino, D; Conte, E; De Bellis, M; De Luca, A; Desaphy, JF; Fonzino, A; Giustino, A; Laghezza, A; Liantonio, A; Loiodice, F; Musaraj, K; Pierno, S; Romano, R1
Chen, F; Chen, H; Cui, W; Jin, Y; Liu, D; Liu, F; Lu, J1
Cui, W; Du, J; Han, M; Liu, DM; Liu, F; Lu, JC; Yin, HN; Zhang, HL; Zhang, K1
Davy, KP; Dengo, AL; Orr, JS; Rivero, JM1
Astarita, G; Barrett, E; Beckett, TL; Dowling, AL; Head, E; Kryscio, RJ; Levine, H; Lin, Y; Morales, J; Murphy, MP; Piomelli, D; Studzinski, CM; Wang, X; Weidner, A1
Abe, K; Ikeda, Y; Kozuki, M; Kurata, T; Matsuura, T; Miyazaki, K; Morimoto, N; Nagai, M; Ohta, Y; Panin, VL1
Clarke, R; Lynch, MA; Lyons, A; Murphy, KJ1
Cheng, QL; Ye, P; Zhao, JH1
Barone, E; Butterfield, DA; Cenini, G; Dowling, AL; Head, E; Mancuso, C; Martin, SB; Murphy, MP1
Han, C; Han, L; Li, M; Liu, Y; Ye, P1
Wang, H; Ye, P; Zhang, JY1
Guo, Y; Wang, J; Xu, D; Xu, J; Yang, Z; Zhang, Y; Zhou, C1
Fürst, DO; Granzow, M; Huss, S; Klein, S; Klösel, J; Körner, C; Lammert, F; Mazar, IG; Nattermann, J; Pieper-Fürst, U; Sauerbruch, T; Schierwagen, R; Trebicka, J; van den Ven, PF; Weber, S1
Blauw, GJ; Meinders, AE; Weverling-Rijnsburger, AW1
Baumeister, B; Berthold, HK; Degenhardt, R; Gouni-Berthold, I; Krone, W; Unverdorben, M; Unverdorben, S; Vetter, H; Zittermann, A1
Alegret, M; Laguna, JC; Roglans, N; Sánchez, RM; Sanguino, E; Vázquez-Carrera, M1
Nachtigal, P; Ouda, L; Semecký, V; Solichová, D; Syka, J1
Arca, M1

Reviews

2 review(s) available for atorvastatin and Aging

ArticleYear
The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study.
    Pharmacogenetics and genomics, 2014, Volume: 24, Issue:1

    Topics: Aged; Aging; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cytosine; Databases, Factual; Dose-Response Relationship, Drug; Female; Genetic Association Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Polymorphism, Single Nucleotide; Prospective Studies; Pyrroles; Risk Factors; Sex Characteristics; Simvastatin; Thymine

2014
Atorvastatin: a safety and tolerability profile.
    Drugs, 2007, Volume: 67 Suppl 1

    Topics: Aged; Aging; Alanine Transaminase; Aspartate Aminotransferases; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Pyrroles

2007

Trials

2 trial(s) available for atorvastatin and Aging

ArticleYear
Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4

    Topics: Adult; Aged; Aging; Atorvastatin; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Double-Blind Method; Elasticity; Female; Femoral Artery; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Obesity; Overweight; Pyrroles; Regional Blood Flow; Risk Factors

2009
Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2004, Volume: 15, Issue:6

    Topics: Aged; Aging; Atorvastatin; Biomarkers; Bone and Bones; Bone Density; Cardiovascular Diseases; Collagen; Collagen Type I; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Multivariate Analysis; Osteocalcin; Peptides; Postmenopause; Prospective Studies; Pyrroles; Risk Factors

2004

Other Studies

26 other study(ies) available for atorvastatin and Aging

ArticleYear
Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
    AIDS (London, England), 2020, 05-01, Volume: 34, Issue:6

    Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Darunavir; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rosuvastatin Calcium; Treatment Outcome

2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:8

    Topics: Aged; Aging; Atorvastatin; Drug Interactions; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged

2020
Atorvastatin attenuates surgery-induced BBB disruption and cognitive impairment partly by suppressing NF-κB pathway and NLRP3 inflammasome activation in aged mice.
    Acta biochimica et biophysica Sinica, 2021, Apr-15, Volume: 53, Issue:5

    Topics: Aging; Animals; Atorvastatin; Blood-Brain Barrier; Cognitive Dysfunction; Inflammasomes; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Surgical Procedures, Operative

2021
Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:3

    Topics: Aged; Aged, 80 and over; Aging; Atorvastatin; Case-Control Studies; Female; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Lovastatin; Male; Muscular Diseases; Myotoxicity; Phenotype; Polymorphism, Single Nucleotide

2021
Protective effect of atorvastatin on d-galactose-induced aging model in mice.
    Behavioural brain research, 2017, 09-15, Volume: 334

    Topics: Aging; Animals; Antioxidants; Anxiety; Atorvastatin; Brain; Brain-Derived Neurotrophic Factor; Cognition; Dose-Response Relationship, Drug; Galactose; Male; Maze Learning; Mice; Models, Animal; Nootropic Agents; Random Allocation; Recognition, Psychology; Superoxide Dismutase

2017
Cilostazol enhances atorvastatin-induced vasodilation of female rat aorta during aging.
    Physiology international, 2017, Sep-01, Volume: 104, Issue:3

    Topics: Aging; Animals; Aorta; Atorvastatin; Cilostazol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; In Vitro Techniques; Rats; Rats, Wistar; Tetrazoles; Treatment Outcome; Vasodilator Agents

2017
[The effect of PPARalpha signal channel on atorvastatin inhibiting MMP-9 expression in aging myocytes].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2013, Volume: 29, Issue:5

    Topics: Aging; Animals; Atorvastatin; Cells, Cultured; Heptanoic Acids; Matrix Metalloproteinase 9; Muscle Cells; Oxazoles; PPAR alpha; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Tyrosine

2013
Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Experimental gerontology, 2014, Volume: 52

    Topics: Aging; Animals; Aorta, Thoracic; Atorvastatin; Body Weight; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyrroles; Rats, Wistar; Sirtuin 1

2014
A calcified left ventricular mass.
    Acta cardiologica, 2014, Volume: 69, Issue:3

    Topics: Aged, 80 and over; Aging; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Calcinosis; Diagnosis, Differential; Female; Heart Neoplasms; Heart Valve Diseases; Heptanoic Acids; Humans; Hypertension; Mitral Valve; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Pyrroles; Quinapril; Radiography; Tetrahydroisoquinolines; Treatment Outcome

2014
Robust and enduring atorvastatin-mediated memory recovery following the 4-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion in middle-aged rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2016, Feb-04, Volume: 65

    Topics: Aging; Amnesia, Retrograde; Animals; Atorvastatin; Brain; Cerebrovascular Disorders; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Maze Learning; Memory; Nootropic Agents; Pyramidal Cells; Rats, Wistar; Treatment Outcome

2016
A non-hypocholesterolemic atorvastatin treatment improves vessel elasticity by acting on elastin composition in WHHL rabbits.
    Atherosclerosis, 2016, Volume: 251

    Topics: Aging; Animals; Aorta; Arteries; Atherosclerosis; Atorvastatin; Blood Pressure; Collagen; Disease Models, Animal; Elastic Modulus; Elastin; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulse Wave Analysis; Rabbits; Stress, Mechanical; Tensile Strength

2016
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin.
    Toxicology and applied pharmacology, 2016, 09-01, Volume: 306

    Topics: Aging; Animals; Atorvastatin; Calcium; Chloride Channels; Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; MEF2 Transcription Factors; Muscle, Skeletal; Muscular Atrophy; Protein Kinase C; Rats, Wistar

2016
Amlodipine and atorvastatin improve ventricular hypertrophy and diastolic function via inhibiting TNF-α, IL-1β and NF-κB inflammatory cytokine networks in elderly spontaneously hypertensive rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83

    Topics: Aging; Amlodipine; Animals; Atorvastatin; C-Reactive Protein; Cardiomegaly; Diastole; Heart Ventricles; I-kappa B Proteins; Inflammation; Interleukin-1beta; Male; Myocardium; NF-kappa B; Rats, Inbred SHR; Rats, Inbred WKY; Tumor Necrosis Factor-alpha

2016
Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:11

    Topics: Aging; Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cardiomegaly; Drug Synergism; Drug Therapy, Combination; Fibrosis; Heart Failure, Diastolic; Hemodynamics; Heptanoic Acids; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Oxidative Stress; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Superoxide Dismutase; Ventricular Dysfunction, Left

2009
Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs.
    Journal of Alzheimer's disease : JAD, 2010, Volume: 22, Issue:1

    Topics: Aging; Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cognition; Discrimination Learning; Dogs; Female; Heptanoic Acids; Male; Protein Processing, Post-Translational; Psychomotor Performance; Pyrroles; Random Allocation; Time Factors

2010
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Brain research, 2011, Jan-31, Volume: 1371

    Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Atorvastatin; Body Weight; Brain; Cognition Disorders; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Organ Size; Phosphorylation; Plaque, Amyloid; Protein Processing, Post-Translational; Pyrroles; Quinolines; tau Proteins

2011
Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain.
    Journal of neuroinflammation, 2011, Mar-31, Volume: 8

    Topics: Aging; Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Atorvastatin; Biomarkers; Brain; Heptanoic Acids; Interferon-gamma; Killer Cells, Natural; Male; Microglia; Natural Cytotoxicity Triggering Receptor 1; NK Cell Lectin-Like Receptor Subfamily B; Pyrroles; Rats; Rats, Wistar

2011
[The effects of atorvastatin on aging kidney].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2011, Volume: 27, Issue:1

    Topics: Aging; Animals; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Female; Heptanoic Acids; Kidney; Kidney Diseases; Pyrroles; Rats; Rats, Wistar; Renal Artery

2011
Coenzyme Q10 and cognition in atorvastatin treated dogs.
    Neuroscience letters, 2011, Aug-26, Volume: 501, Issue:2

    Topics: Aging; Animals; Atorvastatin; Cognition Disorders; Dogs; Female; Heptanoic Acids; Male; Mitochondria; Oxidative Phosphorylation; Oxidative Stress; Parietal Lobe; Pyrroles; Ubiquinone

2011
Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats.
    Pharmacology, 2012, Volume: 89, Issue:1-2

    Topics: Aging; Animals; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Cells, Cultured; Gene Expression Regulation; Heart; Heptanoic Acids; Inflammation Mediators; Myocardium; Oxidoreductases; Peroxisome Proliferator-Activated Receptors; Pyrroles; Rats; Rats, Wistar; Up-Regulation

2012
[Protective effect of atrovastatin against myocardial ischemia-reperfusion injury and on liver and kidney functions in aged rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2012, Volume: 32, Issue:3

    Topics: Aging; Animals; Atorvastatin; Female; Heptanoic Acids; Kidney; Liver; Male; Multiple Organ Failure; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyrroles; Rats; Rats, Wistar

2012
Improvement of arterial stiffness by reducing oxidative stress damage in elderly hypertensive patients after 6 months of atorvastatin therapy.
    Journal of clinical hypertension (Greenwich, Conn.), 2012, Volume: 14, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Anticholesteremic Agents; Arteries; Atorvastatin; Biomarkers; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrroles; Statistics as Topic; Statistics, Nonparametric

2012
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats.
    Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:10

    Topics: Actins; Aging; Animals; Apoptosis; Atorvastatin; beta-Galactosidase; Cell Proliferation; Collagen; Connective Tissue Growth Factor; Desmin; Dose-Response Relationship, Drug; Flow Cytometry; Hepatic Stellate Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Cirrhosis; Male; Myofibroblasts; Pyrroles; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1

2012
Effect of atorvastatin on impaired vascular function in healthy old men.
    Journal of clinical pharmacy and therapeutics, 2004, Volume: 29, Issue:2

    Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Aging; Anticholesteremic Agents; Atorvastatin; Brachial Artery; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Forearm; Heptanoic Acids; Humans; Male; Nitroprusside; Plethysmography; Pyrroles; Reference Values; Regional Blood Flow; Serotonin; Triglycerides; Vasodilation; Vasodilator Agents

2004
Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    British journal of pharmacology, 2005, Volume: 145, Issue:7

    Topics: Aging; Animals; Anticholesteremic Agents; Atorvastatin; Blood Glucose; Cholesterol Esters; Diet; DNA-Binding Proteins; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Heptanoic Acids; Lipid Metabolism; Liver; Liver X Receptors; Male; Orphan Nuclear Receptors; PPAR alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sex Factors; Triglycerides

2005
Atorvastatin slows down the deterioration of inner ear function with age in mice.
    Neuroscience letters, 2007, Jan-10, Volume: 411, Issue:2

    Topics: Acoustic Stimulation; Aging; Animals; Apolipoproteins E; Atorvastatin; Auditory Threshold; Dose-Response Relationship, Radiation; Ear, Inner; Food, Formulated; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Otoacoustic Emissions, Spontaneous; Presbycusis; Pyrroles; Receptors, Vasopressin; Time Factors

2007